NUR 1290 Endocrine

12345678910111213141516
Across
  1. 1. Polyuria, polydipsia, and polyphagia are symptoms of this abnormality associated with poorly managed diabetes.
  2. 3. This lab value shows blood glucose control over the life-span of the RBC molecule, which is approximately 120 days (3-4 months), and target goal for persons with diabetes is 7% or below.
  3. 4. This intermediate-acting insulin has an onset of 1 ½ hours, peak in 6-8 hours, and duration of 22 hours.
  4. 8. This type of insulin order bases the amount of insulin a patient receives on the blood glucose level, is intended to “correct” the current blood glucose, and is not held if the patient is NPO.
  5. 10. Upon assessment the nurse finds a patient confused, with tremors and cool clammy skin which may be indicators of _________________.
  6. 11. This insulin also known as Humalog is a rapid acting SQ insulin which peaks an hour after administration (30-90 min), onset within 15 minutes of administration, and duration of 4-5 hours.
  7. 13. This class of medication often given to suppress the inflammatory or immune response is known to elevate blood glucose levels, potentially requiring temporary insulin administration.
  8. 14. A patient with hypoglycemia who is ___________ or unable to eat or drink safely would receive IV Dextrose 50% (D50W) or glucagon IV, IM or SQ.
  9. 15. The normal range for this common electrolyte is 135 – 145 meq/L.
  10. 16. This medication is used to manage hypothyroidism, and is best taken on an empty stomach first thing in the morning.
Down
  1. 2. The redistribution of adipose tissue occurring when SQ insulin injection sites are not rotated.
  2. 3. Common signs and symptoms of this endocrine abnormality include intolerance to cold, slowed bowel mobility, depression.
  3. 5. Insulin will cause shift this electrolyte into the cells along with glucose; the normal range for this electrolyte is 3.5 – 5.0 meq/L.
  4. 6. This long-acting insulin also known as Glargine, does not have a profound peak and has a duration of 24 hour. It is not to be mixed with any other insulin.
  5. 7. This biguanide is commonly used as first-line therapy for persons with type-2 diabetes, but is temporarily stopped when patients are hospitalized due to decreased metabolism or the drug in the presence of IV contrast dye and potential for damage to the kidneys.
  6. 9. Diabetic ______________ is a complication of diabetes requiring IV insulin (Regular), more often of type-1, where patients present with very high blood glucose levels, ketones present in the blood and urine, and often a fruity smell to the breath due to acidosis.
  7. 12. This short-acting insulin also known as Humulin has a peak of 2-4 hours, has an onset of ½ - 1 hour, and duration of up to 8 hours.